FFCP PHASE1:Hg19::chr17:9955874..9955881,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C359 | |||
|description=CAGE_peak_at_chr17:9955874..9955881,- | |||
|id=chr17:9955874..9955881,- | |||
|ontology_enrichment_celltype=CL:0000945!7.07e-58!24;CL:0000826!7.07e-58!24;CL:0000817!3.79e-36!3;CL:0000838!4.93e-26!52;CL:0000542!1.62e-25!53;CL:0000051!1.62e-25!53;CL:0000785!1.29e-24!2;CL:0000955!1.29e-24!2;CL:0000818!1.29e-24!2;CL:0000954!1.29e-24!2;CL:0000816!1.29e-24!2;CL:0000819!1.82e-13!1;CL:0000946!6.06e-13!1;CL:0000786!6.06e-13!1;CL:0000980!6.06e-13!1;CL:0002087!1.79e-10!119;CL:0002031!5.40e-10!124;CL:0000738!1.09e-08!140;CL:0000236!3.18e-08!14;CL:0002032!3.78e-07!165;CL:0000837!3.78e-07!165;CL:0000037!8.50e-07!172;CL:0000566!8.50e-07!172 | |||
|ontology_enrichment_celltype_v019=CL:0000945;1.51e-41;24!CL:0000785;9.91e-41;1!CL:0000819;9.91e-41;1!CL:0000817;2.70e-40;1!CL:0000236;3.32e-13;13!CL:0000542;4.32e-13;53!CL:0002087;3.47e-08;104 | |||
|ontology_enrichment_celltype_v019_2=CL:0000817,2.87e-53,3;CL:0000945,1.51e-41,24;CL:0000826,1.51e-41,24;CL:0000819,9.91e-41,1;CL:0000785,3.81e-21,2;CL:0000955,3.81e-21,2;CL:0000818,3.81e-21,2;CL:0000954,3.81e-21,2;CL:0000816,3.81e-21,2;CL:0000838,1.25e-19,52;CL:0000542,2.83e-19,53;CL:0000051,2.83e-19,53;CL:0000236,2.37e-12,14;CL:0002087,3.65e-09,115;CL:0002031,8.28e-09,120;CL:0000738,7.64e-08,136 | |||
|ontology_enrichment_development_v019=CL:0000954;3.81e-21;2!CL:0000051;4.32e-13;53 | |||
|ontology_enrichment_disease=DOID:0060058!2.69e-19!10;DOID:630!1.61e-13!1;DOID:0050177!1.61e-13!1;DOID:0050427!1.61e-13!1;DOID:0060073!1.82e-13!1;DOID:8675!1.82e-13!1 | |||
|ontology_enrichment_disease_v019=DOID:630;6.62e-41;1!DOID:0050177;6.62e-41;1!DOID:0050427;6.62e-41;1!DOID:0060073;9.91e-41;1!DOID:8675;9.91e-41;1!DOID:0060058;6.93e-17;10 | |||
|ontology_enrichment_disease_v019_2=DOID:630,6.62e-41,1;DOID:0050177,6.62e-41,1;DOID:0050427,6.62e-41,1;DOID:0060073,9.91e-41,1;DOID:8675,9.91e-41,1;DOID:0060058,6.93e-17,10;DOID:2531,8.60e-08,51;DOID:0060083,8.60e-08,51 | |||
|ontology_enrichment_uberon=UBERON:0002106!3.52e-16!3;UBERON:0004854!3.52e-16!3;UBERON:0009034!3.52e-16!3;UBERON:0002095!3.52e-16!3;UBERON:0004782!3.52e-16!3;UBERON:0003281!3.52e-16!3;UBERON:0009664!3.52e-16!3;UBERON:0002296!3.52e-16!3;UBERON:0005602!3.52e-16!3;UBERON:0001179!3.52e-16!3;UBERON:0006293!3.52e-16!3;UBERON:0000029!3.76e-13!1;UBERON:0002902!9.73e-13!1;UBERON:0009899!9.73e-13!1;UBERON:0004457!3.10e-09!12;UBERON:0000042!3.10e-09!12;UBERON:0004177!1.86e-07!7 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.61130724598361,0.328402357799783,0.0787107813136792,0,0,0,0,0,0,0.542270404062111,0.284338464974843,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144846518960824,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.329294892959902,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.58696134274089,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10776324914963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.83155057352899,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.496166021811951,0,2.9230223611415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0691572524642179,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.230467975111559,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0939839179798536,0.0644578879735772,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.37307532297436 | |||
|short_description=p@chr17:9955874..9955881,- | |||
}} |
Revision as of 13:54, 20 January 2014
Short description: | p@chr17:9955874..9955881, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr17:9955874..9955881, - |
Coexpression cluster: | C359_xeroderma_tonsil_acute_colon_lymph_trachea_bladder |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
precursor B cell | 2.87e-53 | 3 |
lymphocyte of B lineage | 1.51e-41 | 24 |
pro-B cell | 1.51e-41 | 24 |
B-1 B cell | 9.91e-41 | 1 |
mature B cell | 3.81e-21 | 2 |
pre-B-II cell | 3.81e-21 | 2 |
transitional stage B cell | 3.81e-21 | 2 |
small pre-B-II cell | 3.81e-21 | 2 |
immature B cell | 3.81e-21 | 2 |
lymphoid lineage restricted progenitor cell | 1.25e-19 | 52 |
lymphocyte | 2.83e-19 | 53 |
common lymphoid progenitor | 2.83e-19 | 53 |
B cell | 2.37e-12 | 14 |
nongranular leukocyte | 3.65e-09 | 115 |
hematopoietic lineage restricted progenitor cell | 8.28e-09 | 120 |
leukocyte | 7.64e-08 | 136 |
Ontology term | p-value | n |
---|---|---|
genetic disease | 6.62e-41 | 1 |
monogenic disease | 6.62e-41 | 1 |
xeroderma pigmentosum | 6.62e-41 | 1 |
lymphatic system cancer | 9.91e-41 | 1 |
lymphosarcoma | 9.91e-41 | 1 |
lymphoma | 6.93e-17 | 10 |
hematologic cancer | 8.60e-08 | 51 |
immune system cancer | 8.60e-08 | 51 |